img

Global CRISPR-Based Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CRISPR-Based Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases.
CRISPR-Based Therapeutics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CRISPR-Based Therapeutics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biotechnology Companies and Pharmaceutical Companies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CRISPR-Based Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, CRISPR-Based Therapeutics key companies include Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific and Horizon Discovery Group, etc. Caribou Biosciences, Addgene, CRISPR THERAPEUTICS are top 3 players and held % share in total in 2022.
CRISPR-Based Therapeutics can be divided into Genome Editing, Genetic Engineering, gRNA Database/Gene Librar and CRISPR Plasmid, etc. Genome Editing is the mainstream product in the market, accounting for % share globally in 2022.
CRISPR-Based Therapeutics is widely used in various fields, such as Biotechnology Companies, Pharmaceutical Companies, Academic Institutes and Research and Development Institutes, etc. Biotechnology Companies provides greatest supports to the CRISPR-Based Therapeutics industry development. In 2022, global % share of CRISPR-Based Therapeutics went into Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global CRISPR-Based Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Segment by Application


Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CRISPR-Based Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CRISPR-Based Therapeutics introduction, etc. CRISPR-Based Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of CRISPR-Based Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of CRISPR-Based Therapeutics
1.1 CRISPR-Based Therapeutics Market Overview
1.1.1 CRISPR-Based Therapeutics Product Scope
1.1.2 CRISPR-Based Therapeutics Market Status and Outlook
1.2 Global CRISPR-Based Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global CRISPR-Based Therapeutics Market Size by Region (2018-2033)
1.4 Global CRISPR-Based Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global CRISPR-Based Therapeutics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, CRISPR-Based Therapeutics Market Size (2018-2033)
1.6.1 North America CRISPR-Based Therapeutics Market Size (2018-2033)
1.6.2 Europe CRISPR-Based Therapeutics Market Size (2018-2033)
1.6.3 Asia-Pacific CRISPR-Based Therapeutics Market Size (2018-2033)
1.6.4 Latin America CRISPR-Based Therapeutics Market Size (2018-2033)
1.6.5 Middle East & Africa CRISPR-Based Therapeutics Market Size (2018-2033)
2 CRISPR-Based Therapeutics Market by Type
2.1 Introduction
2.1.1 Genome Editing
2.1.2 Genetic Engineering
2.1.3 gRNA Database/Gene Librar
2.1.4 CRISPR Plasmid
2.1.5 Human Stem Cells
2.1.6 Genetically Modified Organisms/Crops
2.1.7 Cell Line Engineering
2.2 Global CRISPR-Based Therapeutics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America CRISPR-Based Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe CRISPR-Based Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific CRISPR-Based Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America CRISPR-Based Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa CRISPR-Based Therapeutics Revenue Breakdown by Type (2018-2033)
3 CRISPR-Based Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Academic Institutes
3.1.4 Research and Development Institutes
3.2 Global CRISPR-Based Therapeutics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America CRISPR-Based Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe CRISPR-Based Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific CRISPR-Based Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America CRISPR-Based Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa CRISPR-Based Therapeutics Revenue Breakdown by Application (2018-2033)
4 CRISPR-Based Therapeutics Competition Analysis by Players
4.1 Global CRISPR-Based Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)
4.3 Date of Key Players Enter into CRISPR-Based Therapeutics Market
4.4 Global Top Players CRISPR-Based Therapeutics Headquarters and Area Served
4.5 Key Players CRISPR-Based Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 CRISPR-Based Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Caribou Biosciences
5.1.1 Caribou Biosciences Profile
5.1.2 Caribou Biosciences Main Business
5.1.3 Caribou Biosciences CRISPR-Based Therapeutics Products, Services and Solutions
5.1.4 Caribou Biosciences CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Caribou Biosciences Recent Developments
5.2 Addgene
5.2.1 Addgene Profile
5.2.2 Addgene Main Business
5.2.3 Addgene CRISPR-Based Therapeutics Products, Services and Solutions
5.2.4 Addgene CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Addgene Recent Developments
5.3 CRISPR THERAPEUTICS
5.3.1 CRISPR THERAPEUTICS Profile
5.3.2 CRISPR THERAPEUTICS Main Business
5.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Products, Services and Solutions
5.3.4 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Merck KGaA Recent Developments
5.4 Merck KGaA
5.4.1 Merck KGaA Profile
5.4.2 Merck KGaA Main Business
5.4.3 Merck KGaA CRISPR-Based Therapeutics Products, Services and Solutions
5.4.4 Merck KGaA CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Merck KGaA Recent Developments
5.5 Mirus Bio LLC
5.5.1 Mirus Bio LLC Profile
5.5.2 Mirus Bio LLC Main Business
5.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Products, Services and Solutions
5.5.4 Mirus Bio LLC CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Mirus Bio LLC Recent Developments
5.6 Editas Medicine
5.6.1 Editas Medicine Profile
5.6.2 Editas Medicine Main Business
5.6.3 Editas Medicine CRISPR-Based Therapeutics Products, Services and Solutions
5.6.4 Editas Medicine CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Editas Medicine Recent Developments
5.7 Takara Bio USA
5.7.1 Takara Bio USA Profile
5.7.2 Takara Bio USA Main Business
5.7.3 Takara Bio USA CRISPR-Based Therapeutics Products, Services and Solutions
5.7.4 Takara Bio USA CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Takara Bio USA Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Products, Services and Solutions
5.8.4 Thermo Fisher Scientific CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Scientific Recent Developments
5.9 Horizon Discovery Group
5.9.1 Horizon Discovery Group Profile
5.9.2 Horizon Discovery Group Main Business
5.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Products, Services and Solutions
5.9.4 Horizon Discovery Group CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Horizon Discovery Group Recent Developments
5.10 Intellia Therapeutics
5.10.1 Intellia Therapeutics Profile
5.10.2 Intellia Therapeutics Main Business
5.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Products, Services and Solutions
5.10.4 Intellia Therapeutics CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Intellia Therapeutics Recent Developments
5.11 GE Healthcare Dharmacon
5.11.1 GE Healthcare Dharmacon Profile
5.11.2 GE Healthcare Dharmacon Main Business
5.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Products, Services and Solutions
5.11.4 GE Healthcare Dharmacon CRISPR-Based Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 GE Healthcare Dharmacon Recent Developments
6 North America
6.1 North America CRISPR-Based Therapeutics Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe CRISPR-Based Therapeutics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CRISPR-Based Therapeutics Market Dynamics
11.1 CRISPR-Based Therapeutics Industry Trends
11.2 CRISPR-Based Therapeutics Market Drivers
11.3 CRISPR-Based Therapeutics Market Challenges
11.4 CRISPR-Based Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market CRISPR-Based Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global CRISPR-Based Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global CRISPR-Based Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global CRISPR-Based Therapeutics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global CRISPR-Based Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global CRISPR-Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2024-2033)
Table 11. North America CRISPR-Based Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America CRISPR-Based Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe CRISPR-Based Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe CRISPR-Based Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific CRISPR-Based Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific CRISPR-Based Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America CRISPR-Based Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America CRISPR-Based Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa CRISPR-Based Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa CRISPR-Based Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global CRISPR-Based Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global CRISPR-Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2024-2033)
Table 26. North America CRISPR-Based Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America CRISPR-Based Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe CRISPR-Based Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe CRISPR-Based Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific CRISPR-Based Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific CRISPR-Based Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America CRISPR-Based Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America CRISPR-Based Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa CRISPR-Based Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa CRISPR-Based Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global CRISPR-Based Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global CRISPR-Based Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR-Based Therapeutics as of 2022)
Table 39. Date of Key Players Enter into CRISPR-Based Therapeutics Market
Table 40. Global CRISPR-Based Therapeutics Key Players Headquarters and Area Served
Table 41. CRISPR-Based Therapeutics Product Solution and Service
Table 42. Global CRISPR-Based Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Caribou Biosciences Basic Information List
Table 45. Caribou Biosciences Description and Business Overview
Table 46. Caribou Biosciences CRISPR-Based Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Caribou Biosciences (2018-2023)
Table 48. Caribou Biosciences Recent Developments
Table 49. Addgene Basic Information List
Table 50. Addgene Description and Business Overview
Table 51. Addgene CRISPR-Based Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Addgene (2018-2023)
Table 53. Addgene Recent Developments
Table 54. CRISPR THERAPEUTICS Basic Information List
Table 55. CRISPR THERAPEUTICS Description and Business Overview
Table 56. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of CRISPR THERAPEUTICS (2018-2023)
Table 58. CRISPR THERAPEUTICS Recent Developments
Table 59. Merck KGaA Basic Information List
Table 60. Merck KGaA Description and Business Overview
Table 61. Merck KGaA CRISPR-Based Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Merck KGaA (2018-2023)
Table 63. Merck KGaA Recent Developments
Table 64. Mirus Bio LLC Basic Information List
Table 65. Mirus Bio LLC Description and Business Overview
Table 66. Mirus Bio LLC CRISPR-Based Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Mirus Bio LLC (2018-2023)
Table 68. Mirus Bio LLC Recent Developments
Table 69. Editas Medicine Basic Information List
Table 70. Editas Medicine Description and Business Overview
Table 71. Editas Medicine CRISPR-Based Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Editas Medicine (2018-2023)
Table 73. Editas Medicine Recent Developments
Table 74. Takara Bio USA Basic Information List
Table 75. Takara Bio USA Description and Business Overview
Table 76. Takara Bio USA CRISPR-Based Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Takara Bio USA (2018-2023)
Table 78. Takara Bio USA Recent Developments
Table 79. Thermo Fisher Scientific Basic Information List
Table 80. Thermo Fisher Scientific Description and Business Overview
Table 81. Thermo Fisher Scientific CRISPR-Based Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Thermo Fisher Scientific (2018-2023)
Table 83. Thermo Fisher Scientific Recent Developments
Table 84. Horizon Discovery Group Basic Information List
Table 85. Horizon Discovery Group Description and Business Overview
Table 86. Horizon Discovery Group CRISPR-Based Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Horizon Discovery Group (2018-2023)
Table 88. Horizon Discovery Group Recent Developments
Table 89. Intellia Therapeutics Basic Information List
Table 90. Intellia Therapeutics Description and Business Overview
Table 91. Intellia Therapeutics CRISPR-Based Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of Intellia Therapeutics (2018-2023)
Table 93. Intellia Therapeutics Recent Developments
Table 94. GE Healthcare Dharmacon Basic Information List
Table 95. GE Healthcare Dharmacon Description and Business Overview
Table 96. GE Healthcare Dharmacon CRISPR-Based Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in CRISPR-Based Therapeutics Business of GE Healthcare Dharmacon (2018-2023)
Table 98. GE Healthcare Dharmacon Recent Developments
Table 99. North America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 100. North America CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 101. Europe CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 102. Europe CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 103. Asia-Pacific CRISPR-Based Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 105. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 106. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2018-2023)
Table 107. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2024-2033)
Table 108. Latin America CRISPR-Based Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Latin America CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 110. Latin America CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 111. Middle East & Africa CRISPR-Based Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 112. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 113. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 114. CRISPR-Based Therapeutics Market Trends
Table 115. CRISPR-Based Therapeutics Market Drivers
Table 116. CRISPR-Based Therapeutics Market Challenges
Table 117. CRISPR-Based Therapeutics Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR-Based Therapeutics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global CRISPR-Based Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global CRISPR-Based Therapeutics Market Share by Regions: 2022 VS 2033
Figure 4. Global CRISPR-Based Therapeutics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America CRISPR-Based Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe CRISPR-Based Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific CRISPR-Based Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America CRISPR-Based Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa CRISPR-Based Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Genome Editing
Figure 11. Global Genome Editing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Genetic Engineering
Figure 13. Global Genetic Engineering Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of gRNA Database/Gene Librar
Figure 15. Global gRNA Database/Gene Librar Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of CRISPR Plasmid
Figure 17. Global CRISPR Plasmid Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Human Stem Cells
Figure 19. Global Human Stem Cells Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Product Picture of Genetically Modified Organisms/Crops
Figure 21. Global Genetically Modified Organisms/Crops Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Product Picture of Cell Line Engineering
Figure 23. Global Cell Line Engineering Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Global CRISPR-Based Therapeutics Market Size Share by Type: 2022 & 2033
Figure 25. North America CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2033)
Figure 26. Europe CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2033)
Figure 27. Asia-Pacific CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2033)
Figure 28. Latin America CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2033)
Figure 29. Middle East and Africa CRISPR-Based Therapeutics Revenue Market Share by Type (2018-2033)
Figure 30. Biotechnology Companies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 31. Pharmaceutical Companies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 32. Academic Institutes Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 33. Research and Development Institutes Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 34. Global CRISPR-Based Therapeutics Market Size Share by Application: 2022 & 2033
Figure 35. North America CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2033)
Figure 36. Europe CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2033)
Figure 37. Asia-Pacific CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2033)
Figure 38. Latin America CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2033)
Figure 39. Middle East and Africa CRISPR-Based Therapeutics Revenue Market Share by Application (2018-2033)
Figure 40. CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 41. Global Top 5 and Top 10 Players CRISPR-Based Therapeutics Market Share in 2022
Figure 42. North America CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 43. United States CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 44. Canada CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 45. Germany CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 46. France CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 47. U.K. CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 48. Italy CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 49. Russia CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 50. Nordic Countries CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 51. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2018-2033)
Figure 52. China CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 53. Japan CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 54. South Korea CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 55. Southeast Asia CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 56. India CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 57. Australia CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 58. Latin America CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 59. Mexico CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 60. Brazil CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 61. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2018-2033)
Figure 62. Turkey CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 63. Saudi Arabia CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 64. UAE CRISPR-Based Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 65. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries